Patent · US Active

Cyclin based inhibitors of CDK2 and CDK4

US8566072B2 · kind B2 · utility

8Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 18, 2011
Grant dateOct 22, 2013
Priority date
Expiry dateJun 16, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16B20/00
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

Structural and functional analysis of peptide inhibitor binding to the cyclin D1 groove has been investigated and used to design peptides that provide the basis for structure-activity relationships, have improved binding and have potential for development as chemical biology probes, as potential diagnostics and as therapeutics in the treatment of proliferative diseases including cancer and inflammation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.